v3.26.1
Accrued Expenses and Other Current Liabilities (FY)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Accrued Expenses and Other Current Liabilities    
Accrued Expenses and Other Current Liabilities
6. Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following:

(in thousands)
March 31, 2026
December 31, 2025
Professional fees
$500
$347
Compensation and related benefits
1,297
2,740
Research and development
1,174
642
Divestiture fee due to Catalent
924
924
 
$3,895
$4,653
7. Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following:

(in thousands)
December 31, 2025
December 31, 2024
Professional fees
$347
$406
Compensation and related benefits
2,740
4,405
Research and development
642
1,896
Divestiture fee due to Catalent
924
 
$4,653
$6,707